Original language | English (US) |
---|---|
Pages (from-to) | S156 |
Journal | Annals of Oncology |
Volume | 34 |
DOIs | |
State | Published - 2023 |
P-409 Outcomes of patients with unresectable hepatocellular carcinoma who developed an infection while receiving atezolizumab: Abstract Book of the ESMO 25th World Congress on Gastrointestinal Cancer 2023, Barcelona, Spain, 28 June - 1 July 2023
A. Esmail, J. Xu, E. Burns, K. Gee, C. Wiechmann, Y. Zhang, R. Kieser, Z. Gong, G. Umoru, S. Shah, K. Sun, K. Heyne, M. Abdelrahim
- Research Institute
- Houston Methodist
- Dr. Mary and Ron Neal Cancer Center
- Academic Institute
- Department of Medicine
- Center for Health Data Science and Analytics
- Weill Cornell Medical College
- Center for Infectious Diseases Research
- Houston Methodist Hospital
- Lynda K. and David M. Underwood Center for Digestive Disorders
Research output: Contribution to journal › Article › peer-review